Biotech - Spark Newswire

1 minute read

AbbVie-Roche’s Venclexta Shows Progression-Free Survival Of 74% In CLL Patients After Three Years Treatment

Today, 11:23 PM

Genentech, a unit of Roche Holdings AG (OTC:RHHBY), and its collaborating partner AbbVie Inc (NYSE:ABBV) have announced long-term follow-up data from two Phase 3…

ABBV

1 minute read

Curis Shares Drop After Updated CA-4948 Data From Mid-Stage Blood Cancer Trial

By Vandana Singh

Today, 11:23 PM

Curis Inc (NASDAQ:CRIS) has announced updated data from its ongoing Phase 1/2 study of CA-4948 in patients with acute myeloid leukemia…

CRIS

1 minute read

Autolus Therapeutics’ CAR T Cell Achieves 100% Complete Remission In Indolent B Cell Non-Hodgkin Cohort

By Vandana Singh

Today, 11:23 PM

Autolus Therapeutics plc (NASDAQ:AUTL) has announced new data from AUTO1 (obecabtagene autoleucel, obe-cel) in relapsed / refractory (r/r) indolent B cell…

AUTL

1 minute read

EMA Says Supervisory Authorities Recommended Not Releasing J&J’s Janssen COVID-19 Vaccine Batches Containing Active Substance Made Around Same Time As Contamination

By Benzinga Newsdesk

Today, 11:23 PM

-Reuters

JNJ

1 minute read

EU Authorities Are Aware That A Batch Of The Active Substance For Janssen COVID-19 Vaccine Had Been Contaminated With Materials For Another Vaccine Manufactured At The Same Site.

By Bill Haddad

Today, 11:23 PM

-Reuters

JNJ

1 minute read

Constellation Pharmaceuticals Highlights Presentation Of Three Posters Relating To MANIFEST Trial Of Pelabresib At European Hematology Association Annual Meeting

By Bill Haddad

Today, 11:23 PM

Constellation Pharmaceuticals, Inc. (NASDAQ:CNST), a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel therapeutics, today announced that three posters relating to

CNST

1 minute read

Atossa Therapeutics Receives Approval From Swedish Regulators To Initiate Phase 2 Clinical Study Of Oral Endoxifen To Reduce Mammographic Breast Density

By Bill Haddad

Today, 11:23 PM

Atossa Therapeutics, Inc. (NASDAQ:ATOS), a clinical-stage biopharmaceutical company seeking to discover and develop innovative medicines in oncology and infectious disease with a current focus on breast cancer and

ATOS

2 minute read

FDA
News

Moderna, Tabuk Pharma Report Partnership To Commercialize Moderna’s COVID-19 Vaccine In Saudi Arabia, No Terms Disclosed

By Benzinga Newsdesk

Today, 11:23 PM

Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Tabuk Pharmaceutical Manufacturing Company (a fully owned subsidiary of Astra Industrial Group), a

MRNA